Thrombelastography today: Practicability and analytical power

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 6, 2007, Pages 421-428

  Hanecke P ^a   Klouche, M ^a,b  

^a Bremer Zentrum fur Laboratoriumsmedizin   (Germany)

^b LADR GmbH Medizinisches Versorgungszentrum Bremen   (Germany)

Author keywords

Accuracy; Cytochalasin D; Robustness; Rotational thrombelastography; RoTEM ; Sample

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; BLOOD; BLOOD CLOTTING; CASE REPORT; DIAGNOSTIC PROCEDURE; GERMANY; HUMAN; MALE; METHODOLOGY; PARTIAL THROMBOPLASTIN TIME; PHYSICIAN; PROTHROMBIN TIME; QUALITY CONTROL; REVIEW; TEMPERATURE ACCLIMATIZATION; THROMBOELASTOGRAPHY;

EID: 37049019050     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110899     Document Type: Review

References (32)

1. Calatzis An, Haas S, Goedje, O, Calatzis Al, Hipp R, Walenga JM: Thrombelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer; in Pifaree R (ed): Management of Bleeding in Cardiovascular Surgery. Philadelphia, Hanley & Belfus, 2000, pp 215-226.
2. Hartert H: Blutgerinnungsstudien mit der Thrombelastographie, einem Untersuchungsverfahren. Klin Wochenschr 1948;26:577-583.
3. Hartert H: Thrombelastography; in Bang NU, Beller FK, Deutsch E, Mammen EF: Thrombosis and Bleeding Disorders. Theory and Methods. Stuttgart, Thieme, 1971, pp 70-76.
4. Chandler WL: The thrombelastograph and the thrombelastograph technique. Semin Thromb Hemost 1995;21(suppl 4):1-6.
5. Weißbach G: Blutgerinnungsdiagnostik in der Klinik. Berlin, Verlag Gesundheit, 1991.
6. Innerhofer P: Perioperatives Gerinnungsmanagement. Hämostaseologie 2006;26:S3-S14.
7. Görlinger K: Gerinnungsmanagement bei Leber-transplantationen. Hämostaseologie 2006;26:S64-S76.
8. Fries D: Dilutionskoagulopathie. Hämostaseologie 2006;26:S15-S19.
9. Spannagel M, Calatzis A: Point-of-Care Analysis des Hä mostasesystems. J Lab Med 2002;26(1/2):68-76.
10. Siau C, Ng HP, Tan GM, Ho BS, Pua HL: In vitro effects of local anaesthetics on the thrombelastographic profile of parturients. Br J Anaesth 2005;94:117-20.
11. Gibbs NM, Yim D, Weightman, Sheminant M, Rowe R: The effect of excess protamine on thromelastography in vitro. Anaesth Intensive Care 2006;34:579-585.
12. Tobias MD, Henry C, Augostides YG: Lidocaine and bupivacaine exert differential effects on whole blood coagulation. J Clin Anesth 1999;11:52-55.
13. Whitten CW, Allison PM, Latson TW, Ivy R, Burkhardt D, Gulden RH, Cochran RP: Evaluation of laboratory coagulation and lytic parameters resulting from autologous whole blood transfusion during primary aortocoronary bypass grafting. J Clin Anesth 1996;8:229-235.
14. Calatzis A, Fritzsche P, Calatzis A, Kling M, Hipp R, SternbergerA: A comparision of the technical principle of the roTEG Coagulation Analyser and conventional thrombelastographic systems. Ann Hematol 1996;72(suppl 1):142-146.
15. Gengenwin N, Steib A, Freys G, Levy S, Wolf P, Otteni JC: Monitoring of hemostasis during liver transplantation; contribution of thromboelastography. Ann Fr Anesth Reanim 1993;12:544-51.
16. Neumeister B, Besenthal I, Liebich H, Böhm BO: Klinikleitfaden Labordiagnostik, 3. Auflage. München, Urban & Fischer, 2003.
17. Barthels M, von Depka, M: Das Gerinnungskompendium. Stuttgart, Thieme, 2003.
18. Barthels M: Screening-Methoden in der Hämostase. Hämostaseologie 1999;19:146-152.
19. Traverso CI, Caprini JA, Arcelus JI: The normal thrombelastogram and ist interpretation. Semin Thromb Hemost 1995;21(suppl 4):7-13.
20. Keller H: Klinisch-chemische Labordiagnostik für die Praxis. Stuttgart, Thieme, 1986.
21. Pentapharm GmbH, Stahlgruberring 12, D-81829 München: RoTROL N, instructions for use/ Gebrauchsanweisung 2004-09 V 0005 DE.
22. Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Dtsch Ärztebl 2001;98(42):2747-2759.
23. DIN Deutsches Institut für Normung e. V. 2002; in DIN-Taschenbuch 261 Hämostaseologie - DIN 58905-1:2000-03, 2. Auflage. Berlin, Beuth, 2002.
24. Dörner K: Klinische Chemie und Hämatologie, 6. Aufl. Stuttgart, Thieme, 2006.
25. Schafer AI: Thrombocytosis. N Engl J Med 2004;350:1211-1219.
26. Pentapharm GmbH, Stahlgruberring 12, D-81829 München: reference values/ Referenzbereiche, 2005.
27. Lang T, Toller W, Gütl M, Mahla E, Metzler H, Rehak P, März, W, Halwachs-Baumann, G: Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004;2:147-153.
28. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker J, Zimpfer M: Use of ab-ciximab-modified thrombelastography in patients undergoing cardiac surgery. Anaest Analg 1999;89:580-584.
29. Griesshammer M: Options in the management of essential thrombocythaemia. Eur J Haematol 2007;68:S35-39.
30. Griesshammer M: Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia. Semin Thromb Hemost 2006;32:372-380.
31. Griesshammer M: Essential thrombocythemia/polycythemia vera and pregnancy: the need for an observational study in Europe. Semin Thromb Hemost 2006;32:422-429.
32. DIN Deutsches Institut für Normung e. V.: Normenausschuss Laborgeräte und Laboreinrichtungen - DIN EN ISO 8655-2: 2002-12. Berlin, Beuth, 2002.